Global Health Impact Index can help assess effectiveness of key drugs
PLOS ONE: The Global Health Impact Index: Promoting Global Health
Nicole Hassoun, associate professor of philosophy and director of graduate studies at Binghamton University, “presents a model measuring companies’ key malaria, TB, and HIV/AIDS drugs’ consequences for global health … [and] aggregates drugs’ impacts in several ways — by disease, country, and originator-company.” The paper describes the author’s Global Health Impact Index (12/11).
